Disease Modeling
International Conference: 21-22 May 2026, Berlin, Germany
From Development to Practical and Commercial Use
The conference provides a platform for researchers, technologists, and industry experts to explore advances in disease modeling. Sessions will focus on showcasing innovative disease models, recent development successes, and practical strategies for the development, application, collaborative use, and commercial translation of disease models.
Keywords: disease models, organoid systems, in vitro platforms, multi-disease models, predictive and translational modeling, model development, innovative approaches, preclinical testing, translational applications, custom models, commercialization, drug discovery
Interdisciplinary meetup: who should attend
- Researchers developing and applying human disease models, including organoid- and in vitro-based systems
- Engineers and technologists supporting disease model development and integration
- Computational modelers contributing to predictive and translational research
- R&D leads and product managers driving model implementation and applications
- Industry partners and solution providers offering disease modeling platforms and services
Topics
including but not limited to:
Disease Modeling Technologies
Practical technologies for disease modeling, including in vitro model platforms, computational simulation, and integrated experimental–digital modeling approaches.
Novel Human Disease Models for Industry Adoption
Showcase of novel human disease models and recent development successes, along with discussion of practical approaches for industry access, collaboration, and licensing that enable adoption by end users in academia, industry, or both.
Customized Disease Model Development and Services
Design, development, and delivery of customized human disease models for client-specific needs, with end-to-end process control including functional validation, model optimization, and ongoing support.
Special Track: Organoids in Disease Modeling
Development and application of organoid-based disease models, highlighting advances in model design, functional validation, and their use in mechanistic studies, drug discovery, and translational research.
Connecting Industry and Academia
This conference goes beyond traditional discussions of disease modeling. It serves as a forum and meeting point where researchers, technologists, and industry experts showcase innovative disease models, emerging platforms, and approaches supporting their development, practical application, and translation for academic and industrial participants.
By connecting participants across the value chain, the Conference fosters interdisciplinary exchange that drives technology transfer, commercialization, and real-world application of innovations.
